CompaniesRemark Pharma Services & Consulting

Remark Pharma Services & Consulting

active
Oberschleißheim, Germany
Founded 1999
Website
About

Consulting Services

Areas of Focus

Categories

Cg Medical WritingCg RegulatoryCg Strategy
Clinical Trials (9)
View all

Total Trials

9

As Lead Sponsor

1

As Collaborator

8

Total Enrollment

172

By Phase

NA: 1PHASE1/PHASE2: 7PHASE4: 1

By Status

COMPLETED: 5TERMINATED: 2UNKNOWN: 1WITHDRAWN: 1
Clinical Trials Pipeline9 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Today
NCT01808638
NCT02472938
NCT02742844
NCT03257098
NCT03267784
NCT03339973
NCT03529877
NCT03549299
Hover over trial bars to see details

Recent Trials

NCT04905368Lead Sponsor
Safety Evaluation of SS-POR11
NACompleted
20 participants
Started: May 12, 2021 · Completed: Aug 18, 2021
NCT03549299Collaborator
Allogeneic ABCB5-positive Limbal Stem Cells for Treatment of LSCD
PHASE1/PHASE2Unknown
16 participants
Started: Jul 4, 2019 · Completed: Sep 30, 2023
NCT03529877Collaborator
Allogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis Bullosa
PHASE1/PHASE2Completed
16 participants
Started: Feb 16, 2019 · Completed: Nov 26, 2021
NCT03339973Collaborator
Allogeneic ABCB5-positive Stem Cells for Treatment of PAOD
PHASE1/PHASE2Terminated
24 participants
Started: Mar 5, 2018 · Completed: May 15, 2020
NCT03267784Collaborator
"Allogeneic ABCB5-positive Stem Cells for Treatment of DFU Malum Perforans"
PHASE1/PHASE2Completed
23 participants
Started: Nov 21, 2017 · Completed: Jun 29, 2020
View all 9 trials →
Locations (1)
Headquarters
Oberschleißheim, Germany
Map

Loading map...